PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+10.64%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.37B
AUM Growth
+$2.37B
(-9.4%)
Cap. Flow
-$299M
Cap. Flow
% of AUM
-12.64%
Top 10 Holdings %
Top 10 Hldgs %
36.09%
Holding
95
New
14
Increased
16
Reduced
24
Closed
14
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$30.4M |
| 2 |
Agilent Technologies
A
|
$27.5M |
| 3 |
Elevance Health
ELV
|
$21.2M |
| 4 |
Arcellx
ACLX
|
$19.1M |
| 5 |
Universal Health Services
UHS
|
$17.5M |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$83.4M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$76.2M |
| 3 |
Axsome Therapeutics
AXSM
|
$43.7M |
| 4 |
Veeva Systems
VEEV
|
$33.4M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$26.3M |
Sector Composition
| 1 | Healthcare | 95.68% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Tenet Healthcare
THC
$16.3B
| $12.4M | 0.44% | 254,525 -290,058 | -53% | -$14.2M |
|
52
Pulmonx
LUNG
$69.7M
| $12.3M | 0.44% | 1,455,770 +1,256,067 | +629% | +$10.6M |
|
|
OSH
53
DELISTED
Oak Street Health, Inc.
OSH
| $12.2M | 0.44% | 565,239 -157,605 | -22% | -$3.39M |
|
54
Generation Bio
GBIO
$40.4M
| $11.4M | 0.41% | 2,903,192 -110,520 | -4% | -$434K |
|
55
Celcuity
CELC
$2.17B
| $9.98M | 0.36% | 712,111 +571,685 | +407% | +$8.01M |
|
56
ESSA Pharma
EPIX
$11.4M
| $9.69M | 0.35% | 3,844,332 +2,366,080 | +160% | +$5.96M |
|
|
ADAP
57
Adaptimmune Therapeutics
ADAP
$15.6M
| $7.07M | 0.25% | 4,843,510 -4,477,074 | -48% | -$6.54M |
|
58
Praxis Precision Medicines
PRAX
$958M
| $6.61M | 0.24% | 2,777,467 -681,058 | -20% | -$1.62M |
|
|
BPMC
59
DELISTED
Blueprint Medicines
BPMC
| $5.71M | 0.2% | 130,366 | – | – |
|
|
VERV
60
DELISTED
Verve Therapeutics
VERV
| $4.2M | 0.15% | 217,302 -951,506 | -81% | -$18.4M |
|
|
CMPS
61
Compass Pathways
CMPS
$424M
| $4.09M | 0.15% | 509,625 +111,914 | +28% | +$899K |
|
62
Labcorp
LH
$23.1B
| $3.19M | 0.11% | +13,561 | New | +$3.19M |
|
63
PMV Pharmaceuticals
PMVP
$74.2M
| $2.9M | 0.1% | 333,716 -521,448 | -61% | -$4.54M |
|
64
Werewolf Therapeutics
HOWL
$59.9M
| $2.65M | 0.09% | 1,293,293 -1,522,361 | -54% | -$3.12M |
|
|
BLUE
65
DELISTED
bluebird bio
BLUE
| $1.69M | 0.06% | +244,867 | New | +$1.69M |
|
66
iTeos Therapeutics
ITOS
$449M
| $1.39M | 0.05% | 70,922 -467,032 | -87% | -$9.12M |
|
67
IO Biotech
IOBT
$104M
| $1.17M | 0.04% | 507,640 -1,651,515 | -76% | -$3.8M |
|
68
Keros Therapeutics
KROS
$618M
| $768K | 0.03% | +15,999 | New | +$768K |
|
69
Xenon Pharmaceuticals
XENE
$2.98B
| $690K | 0.02% | +17,488 | New | +$690K |
|
|
BLU
70
DELISTED
BELLUS Health Inc.
BLU
| $525K | 0.02% | +63,864 | New | +$525K |
|
|
JNCE
71
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $384K | 0.01% | 345,926 -3,748,562 | -92% | -$4.16M |
|
72
Sana Biotechnology
SANA
$777M
| $248K | 0.01% | 62,776 -628,688 | -91% | -$2.48M |
|
|
VECT
73
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $221K | 0.01% | +25,541 | New | +$221K |
|
74
Biohaven
BHVN
$1.63B
| $153K | 0.01% | +10,988 | New | +$153K |
|
75
Iovance Biotherapeutics
IOVA
$807M
| $85.2K | ﹤0.01% | +13,337 | New | +$85.2K |
|